MEHJABEEN MUJTABA: Open Payments
NPI 1497432587 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 19 payments from 10 companies in 2025. Trend: 2023 $593 · 2024 $941 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $293 |
| Amgen Inc. | 5 | $252 |
| AstraZeneca Pharmaceuticals LP | 3 | $154 |
| Corcept Therapeutics | 1 | $143 |
| Braeburn Inc. | 1 | $122 |
| ABIOMED | 1 | $113 |
| Lilly USA, LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
Products named: REZDIFFRA, Korlym, AIRSUPRA, REPATHA, BRIXADI, EVENITY, MOUNJARO, Kerendia.
Industry payments across NJ — which companies pay providers there.
